Preclinical News and Research

RSS
Mississippi researchers work on drug discovey for poison ivy skin rash

Mississippi researchers work on drug discovey for poison ivy skin rash

Hadasit, Yissum license innovative regenerative membrane implant to RegeneCure

Hadasit, Yissum license innovative regenerative membrane implant to RegeneCure

AusBiotech, WMDO to offer online medtech courses

AusBiotech, WMDO to offer online medtech courses

USPTO grants patent to Symphogen's Sym004 to treat solid tumors

USPTO grants patent to Symphogen's Sym004 to treat solid tumors

Duchenne Parent Project awards grant to AMT for DMD gene therapy

Duchenne Parent Project awards grant to AMT for DMD gene therapy

Galderma, Astrazeneca collaborate to develop new compounds for dermatological disorders

Galderma, Astrazeneca collaborate to develop new compounds for dermatological disorders

NCRM, CSCRM to become national force in regenerative medicine

NCRM, CSCRM to become national force in regenerative medicine

Sangamo's preclinical ZFN-gene modification studies for HIV/AIDS treatment presented at CROI

Sangamo's preclinical ZFN-gene modification studies for HIV/AIDS treatment presented at CROI

Palatin receives FDA clearance to begin PL-3994 Phase 2A trial for asthma treatment

Palatin receives FDA clearance to begin PL-3994 Phase 2A trial for asthma treatment

Sinovac submits clinical trial application for 13-valent pneumococcal conjugate vaccine to China SFDA

Sinovac submits clinical trial application for 13-valent pneumococcal conjugate vaccine to China SFDA

Infinity commences IPI-926 Phase 2 clinical trial in rare, life-threatening bone cancer

Infinity commences IPI-926 Phase 2 clinical trial in rare, life-threatening bone cancer

Lixte receives $244,479.25 U.S. government grant for QTDP program

Lixte receives $244,479.25 U.S. government grant for QTDP program

ITI, Takeda collaborate to develop and commercialize PDE1 inhibitors for schizophrenia

ITI, Takeda collaborate to develop and commercialize PDE1 inhibitors for schizophrenia

IAVI, THSTI collaborate to establish HIV Vaccine Design Program in India

IAVI, THSTI collaborate to establish HIV Vaccine Design Program in India

Oxygen Biotherapeutics receives U.S. Army grant for studies of Oxycyte

Oxygen Biotherapeutics receives U.S. Army grant for studies of Oxycyte

Achillion fourth quarter revenue is $2 million for three months ended December 31, 2010

Achillion fourth quarter revenue is $2 million for three months ended December 31, 2010

Allergan initiates AGN-214868 Phase II trials in post herpetic neuralgia and overactive bladder

Allergan initiates AGN-214868 Phase II trials in post herpetic neuralgia and overactive bladder

U.S. Army awards Oxygen Biotherapeutics two-year grant to study Oxycyte PFC emulsion against TBI

U.S. Army awards Oxygen Biotherapeutics two-year grant to study Oxycyte PFC emulsion against TBI

Pluristem's PLX cells exhibit potential to treat accidental and intentionally induced muscle injuries

Pluristem's PLX cells exhibit potential to treat accidental and intentionally induced muscle injuries

Geron's hESC derived GRNCM1 halts remodeling process and preserves cardiac function in acute heart damage

Geron's hESC derived GRNCM1 halts remodeling process and preserves cardiac function in acute heart damage

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.